OpenLoop

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Branded and compounded GLP-1s (supplied to partner brands)Type not stated

What they publish

OpenLoop publishes 1 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

Not a consumer product — no consumer pricing published (as published)

Medication cost

Not publicly disclosed on the pages we captured.

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Notes it excludes Mississippi for compounded GLP-1 medications, an example of the state-by-state variation that affects consumer brands built on this infrastructure.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• This is infrastructure, not a service you sign up for. It supplies clinicians and fulfilment to consumer-facing weight loss brands.
• Understanding this layer explains a real phenomenon: several apparently independent brands can run on the same clinician network and the same pharmacies.
• States it offers both branded and compounded GLP-1s to partners, with Mississippi excluded for compounded products.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• If you are comparing two consumer brands, they may be running on the same underlying network — ask each who employs the prescribing clinician.
• State-level exclusions like the Mississippi one propagate to the consumer brands built on top.

Frequently asked